These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16191069)

  • 1. The marginal cost of satellite versus in-center hemodialysis.
    Soroka SD; Kiberd BA; Jacobs P
    Hemodial Int; 2005 Apr; 9(2):196-201. PubMed ID: 16191069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis and health-related quality of life of home and self-care satellite haemodialysis.
    Malmström RK; Roine RP; Heikkilä A; Räsänen P; Sintonen H; Muroma-Karttunen R; Honkanen E
    Nephrol Dial Transplant; 2008 Jun; 23(6):1990-6. PubMed ID: 18223263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three financial strategies.
    West DA
    J Health Care Finance; 2003; 30(1):10-22. PubMed ID: 12967240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs associated with erythropoiesis-stimulating agent administration to hemodialysis patients.
    Churchill DN; Macarios D; Attard C; Kallich J; Goeree R
    Nephron Clin Pract; 2007; 106(4):c193-8. PubMed ID: 17596729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocturnal haemodialysis: an Australian cost comparison with conventional satellite haemodialysis.
    Agar JW; Knight RJ; Simmonds RE; Boddington JM; Waldron CM; Somerville CA
    Nephrology (Carlton); 2005 Dec; 10(6):557-70. PubMed ID: 16354238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying cost management strategies in dialysis clinics: sustainable savings with positive outcomes.
    West TD; Gupta M; Balas EA; West DA
    Am J Manag Care; 2002 May; 8(5):449-60. PubMed ID: 12019597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.
    Bhat P; Sokolowski W; Bhat JG
    Nephrol News Issues; 2009 Jun; 23(7):46, 48-52. PubMed ID: 19585810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada.
    McFarlane PA
    Semin Dial; 2004; 17(2):118-24. PubMed ID: 15043613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost of dialysis in France].
    Benain JP; Faller B; Briat C; Jacquelinet C; Brami M; Aoustin M; Dubois JP; Rieu P; Behaghel C; Duru G
    Nephrol Ther; 2007 Jun; 3(3):96-106. PubMed ID: 17540311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care resource use associated with integrated psychological treatment.
    Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
    J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands.
    Beby AT; Cornelis T; Zinck R; Liu FX
    Adv Ther; 2016 Nov; 33(11):2032-2048. PubMed ID: 27664108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Economic Assessment Model of Rural and Remote Satellite Hemodialysis Units.
    Ferguson TW; Zacharias J; Walker SR; Collister D; Rigatto C; Tangri N; Komenda P
    PLoS One; 2015; 10(8):e0135587. PubMed ID: 26284357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estimating the cost savings due to the effect of Kremezin in delaying the initiation of dialysis treatments among patients with chronic renal failure].
    Kang HY; Cho W; Lee S; Kim HJ; Lee HY; Woo TW
    J Prev Med Public Health; 2006 Mar; 39(2):149-58. PubMed ID: 16615270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose hemodialysis versus conventional in-center hemodialysis: a cost-utility analysis from a UK payer perspective.
    Liu FX; Treharne C; Arici M; Crowe L; Culleton B
    Value Health; 2015 Jan; 18(1):17-24. PubMed ID: 25595230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis cost in Tehran, Iran.
    Mahdavi-Mazdeh M; Zamani M; Zamyadi M; Rajolani H; Tajbakhsh K; Heidary Rouchi A; Aghighi M; Mahdavi A
    Hemodial Int; 2008 Oct; 12(4):492-8. PubMed ID: 19090872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Approximation to cost analysis of various types of hemodialysis using relative value units].
    Hernández-Jaras J; García H; Bernat A; Cerrillo V
    Nefrologia; 2000; 20(3):284-90. PubMed ID: 10917006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.